实验概要
E.Z.N.A.® Total RNA Midiprep Kit provides a rapid and easy method for the isolation of up to 600 ug of total RNA from cultured eukaryotic cells, tissues, or bacteria. The kit allows single or multiple, simultaneous processing of samples in less than 40 min. Normally, 5 x 106 - 1 x 108 eukaryotic cells, 5 x 108-1 x 1010 bacterial cells, or 25- 200 mg tissue can be used in a single experiment. There is no need for phenol/chloroform extractions, and time-consuming steps such as CsCl gradient ultracentrifugation, and precipitation with isopropanol or LiCl, are eliminated. While this kit may be used for isolation of RNA from whole blood, we recommend you use the E.Z.N.A.® Blood RNA Kit (product # R6614/R6615) as it is specifically designed for effective hemolysis and hemoglobin removal and gives higher RNA yields.
RNA purified using the E.Z.N.A.® Total RNA method is ready for applications such as RT-PCR*, Northern blotting, poly A RNA (mRNA) purification, nuclease protection, and in vitro translation.
实验原理
The E.Z.N.A. Total RNA Midiprep Kits use the reversible binding properties of HiBind® matrix, a new silica-based material. This is combined with the speed of mini-column spin technology. A specifically formulated high salt buffer system allows more than 600 ug of RNA molecules greater than 200 bases to bind to the matrix. Cells or tissues are first lysed under denaturing conditions that practically inactivate RNases. After the homogenization process by either bead-milling or rotor-stator homogenizer, samples are then applied to the HiBind® Midi spin columns to which total RNA binds, after few quick washing step, cellular debris and other contaminants are effectively washed away. High quality RNA is finally eluted in DEPC-treated sterile water
主要试剂
1. 2-mercaptoethanol
2. 70% ethanol in DEPC-treated sterile distilled water
主要设备
1. Swinging-bucket centrifuge capable of 5000 x g with adaptor for 15 ml tube.
2. Sterile RNase-free pipette tips and 15 centrifuge tubes
3. Disposable latex gloves
实验步骤
1. Disrupt cells or tissues with 2 ml of TRK Lysis Buffer. Remember to add 20 ul of 2-mercaptoethanol per 1 ml of TRK Lysis Buffer before use. Homogenize cells with a rotor-stator homogenizer or vortex.
2 ml of TRK Lysis Buffer is sufficient for 108 cells or approximately 200 mg disrupted tissue (~3 mm cube). For difficult tissues, more than 108 cells, or greater than 200 mg tissue, use 4 ml of TRK Lysis Buffer. However, use no more than 300 mg tissue.
For tissue culture cells grown in monolayer (fibroblasts, endothelial cells, etc.), lyse the cells directly in the culture vessel as follows. Aspirate culture medium completely and add TRK Lysis Buffer directly to the cells. Use 800 ul for each T35 flasks or 10 cm dishes, and 400 ul for each smaller vessels. Pipette buffer over entire surface of vessel to ensure complete lysis. Transfer lysate from all flask to a clean 15 or 50 ml centrifuge tube and proceed to step 2 below. (This method is preferable to trypsinization followed by washing because it minimizes RNA degradation by nuclease contamination.)
For cells grown in suspension cultures, pellet cells at no greater than 1,500 rpm (400 x g) for 5 min. Discard supernatant, add TRK Lysis Buffer, lyse by pipetting up and down, and transfer to a clean 15 or 50 ml microfuge tube. Proceed to step 2.
For tissue samples, homogenize using one of the methods discussed. Unless using liquid nitrogen, disrupt and homogenize samples directly in TRK Lysis Buffer/2-mercaptoethanol and proceed to step.
Note: incomplete homogenization of the sample will cause lower yields and clogging of the column. It is recommended to homogenize the sample with rotor-stator homogenizers since it normally produce better yield.
2. Spin at 5,000 x g for 10 min at room temperature. Transfer the supernatant into a new tube and add an equal volume (2ml or 4ml) 70% Ethanol to the lysate and mix thoroughly by vortexing.
3. Apply sample onto HiBind® RNA Midi column. The maximum capacity of the Midi column is 3.5 ml. (Larger volumes can be loaded successively.) A precipitate may form on addition of ethanol in step 2. Vortex and add the entire mixture to the column. With the spin column inside the 15 ml collecting tube (supplied with kit), centrifuge at 4,000-5,000x g for 5 min at room temperature. Discard flow-through and proceed to step 4.
4. Wash column with RNA Wash Buffer I by pipetting 3.5 ml directly into the spin column. Centrifuge as above and discard the 15 ml collection tube.
Note: This the starting point if on-membrane Dnase I digestion (page 6) is desired.
5. Place column in a clean 15 ml collection tube, and add 3 ml RNA Wash Buffer II diluted with ethanol. Centrifuge at 4,000-5,000 x g for 5 minutes at room temperature. Discard flow-through and reuse the collection tube in step 6.
Note: RNA Wash Buffer II Concentrate must be diluted with absolute ethanol before use. Refer to label on bottle for directions.
6. Wash column with a second 3 ml of RNA Wash Buffer II as in step 5. Centrifuge and discard flow-through. Then with the collection tube empty, centrifuge the spin cartridge for 10 min at 5000 x g to completely dry the HiBind® matrix.
7. Elution of RNA. Transfer the column to a clean 15 ml centrifuge tube (Not supplied) and elute the RNA with 250-500ul of DEPC-treated water (supplied with kit). Make sure to add water directly onto column matrix. Centrifuge 5 min at 4,000-5,000 x g. A second elution may be necessary if the expected yield of RNA >500 ug.
Alternatively, RNA may be eluted with a greater volume of water. While additional elutions increase total RNA yield, the concentration will be lowered since more than 80% of RNA is recovered with the first elution. Pre-heating the water to 70°C before adding to column and incubating column 5 min at room temperature before centrifugation may increase yields.
据27日《自然》杂志报道,英国伦敦大学学院(UCL)化学家通过模拟早期地球的条件,首次实现了RNA与氨基酸的化学连接。这一难题自20世纪70年代以来一直困扰着科学家,如今,这一突破性成果为解答生命起源......
美国芝加哥大学团队开发了一种更为灵敏的液体活检技术,该方法利用RNA而不是传统的DNA来检测癌症。这一创新方法在使用患者血液样本进行测试时,识别出早期结直肠癌的准确率达到95%,显著优于现有的非侵入性......
由新加坡科技研究局基因组研究所领导的科学家团队,发布了迄今全球最大、最全面的长读长RNA测序数据集之一——新加坡纳米孔表达数据集(SG-NEx)。这一成果有望解决疾病研究中长期存在的技术瓶颈,使研究人......
4月15日,中国工程院院士、中国科学院亚热带农业生态研究所首席研究员印遇龙领衔的单胃动物营养研究团队在科技合作和成果转化上取得新进展。其团队博士生王芳以“RNA技术研发与产业化应用”为主的项目,历经初......
近日,中山大学生命科学学院教授张锐团队首次提出名为MIRROR的全新内源性ADAR招募gRNA设计理念,显著提高了RNA编辑效率,这一突破为RNA编辑技术走向临床应用注入了强劲动力,同时也为相关疾病的......
中国科学院分子细胞科学卓越创新中心陈玲玲研究组揭示了双链RNA依赖的蛋白激酶R(PKR)在阿尔茨海默病(AD)发生与进展过程中异常激活的分子病理特征,开发了基于具有分子内短双链结构环形RNA(ds-c......
在癌症治疗领域,化疗药物耐药性问题一直是阻碍治疗效果提升的关键瓶颈。癌细胞拥有多种复杂的机制,能够巧妙地逃避化疗药物的“攻击”,其中,高活性的抗氧化系统可以有效减轻药物诱导的活性氧(ROS)损伤,成为......
比利时布鲁塞尔自由大学主导的一项研究揭示,DNA和RNA的表观遗传学协同调控比过去想象的更加紧密。这项发表在最新一期《细胞》杂志上的研究,结合了DNA和RNA研究结果,指出这两种调控方式共同作用,形成......
近日,广州医科大学-中国科学院广州生物医药与健康研究院联合生命科学学院特聘教授、广州实验室研究员苗智超团队与合作者,对来自全球18个团队的预测进行了大规模评估,涉及23个RNA结构,包括RNA元件、适......
瑞典卡罗琳斯卡医学院等机构研究人员开发出一种突破性的显微镜方法,能够以细胞级分辨率对完整的小鼠大脑进行详细的三维RNA分析。发表在最新一期《科学》杂志上的这种名为TRISCO的新方法,有可能改变人们对......